Ivermectin Dosing for Scabies in a 159-lb Female
For a 159-lb (72 kg) female with scabies, administer oral ivermectin 200 mcg/kg (approximately 14.4 mg total dose), repeated in 2 weeks, taken with food. 1
Specific Dosing Calculation
- Body weight: 159 lb = 72 kg
- Dose: 200 mcg/kg × 72 kg = 14,400 mcg (14.4 mg)
- Using 3-mg tablets: 5 tablets per dose 2
- Timing: Day 0 and Day 14 1
Critical Administration Instructions
Take ivermectin with food to increase bioavailability by approximately 2.5-fold, which enhances drug penetration into the epidermis where the mites reside. 1, 2 This is essential for optimal efficacy.
Why Two Doses Are Non-Negotiable
The second dose at 2 weeks is mandatory because ivermectin has limited ovicidal (egg-killing) activity. 1 Without the second dose:
- Treatment failure occurs in 42% of patients (single dose) versus only 2% with two doses 3
- Single-dose regimens show only 58% cure rates compared to 98% with double-dose protocols 3
- Absence of a second dose is the main predictor of treatment failure (P < 0.001) 3
Comparative Efficacy Considerations
While the CDC guidelines list both permethrin 5% cream and ivermectin as recommended regimens 1, recent high-quality evidence shows permethrin 5% cream is superior:
- A 2026 multicenter cluster randomized trial demonstrated permethrin achieved 88.5% cure rates versus 71.8% for ivermectin (16.7 percentage point difference, 95% CI -26.3 to -7.1) 4
- However, ivermectin remains highly valuable when topical therapy fails or is impractical, with 81.36% of patients resistant to other treatments responding to ivermectin 5
Essential Adjunctive Measures
Environmental decontamination is required:
- Machine-wash and machine-dry all bedding and clothing using hot cycles, or dry clean 1
- Alternatively, remove items from body contact for at least 72 hours 1
- Store clothes in plastic bags for 4 days for enhanced decontamination 6
- Vacuum clean car seats 6
Treat all household contacts simultaneously with the same regimen, even if asymptomatic, to prevent reinfection. 1
Safety Profile
Ivermectin is well-tolerated in this population:
- Cutaneous adverse events occur in approximately 11.9% of patients, typically mild 4
- No dose adjustments needed for renal impairment 1
- Classified as "human data suggest low risk" in pregnancy 1
- One study showed increased mortality in elderly, debilitated persons, but this has not been confirmed in subsequent reports 1
Common Pitfall to Avoid
Post-treatment pruritus does not indicate treatment failure. Itching and rash may persist for up to 2 weeks after successful mite eradication due to ongoing inflammatory response. 1 This is not a reason for re-treatment. Consider topical corticosteroids and oral antihistamines for symptom relief. 7
When to Reassess
Re-evaluate at 2-4 weeks post-treatment. 8 If symptoms persist beyond 2 weeks, consider:
- Treatment resistance or faulty application
- Reinfection from untreated contacts or contaminated fomites 1
- Need for alternative therapy 1
Special Circumstances
For crusted (Norwegian) scabies, a more intensive regimen is required: ivermectin 200 mcg/kg on days 1,2,8,9, and 15, combined with daily topical permethrin. 1 This patient's presentation does not suggest this severe variant.